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ABSTRACT 26	  
Despite significant public health impact, there is no specific antiprotozoal therapy for 27	  
prevention and treatment of Acanthamoeba castellanii infection. There is a need for new and 28	  
efficient anti-Acanthamoeba drugs that are less toxic and can reduce treatment duration and 29	  
frequency of administration. In this context a new, rapid and sensitive assay is required for 30	  
high-throughput activity testing and screening of new therapeutic compounds. A colorimetric 31	  
assay based on sulforhodamine B (SRB) staining has been developed for anti-Acanthamoeba 32	  
drug susceptibility testing and adapted to a 96-well microtiter plate format. Under these 33	  
conditions chlorhexidine was tested to validate the assay using two clinical strains of A. 34	  
castellanii (Neff strain, T4 genotype [IC50 4.68±0.6 µM] and T3 genotype [IC50 5.69±0.9 35	  
µM]). These results were in good agreement with those obtained by the conventional Alamar 36	  
Blue assay, OCR cytotoxicity assay and manual cell counting method. Our new assay offers 37	  
an inexpensive and reliable method, which complements current assays by enhancing high-38	  
throughput anti-Acanthamoeba drug screening capabilities. 39	  
 40	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1.   Introduction 43	  
Acanthamoeba, an opportunistic ubiquitous protist, exists in two morphological stages 44	  
during its life cycle: a vegetative trophozoite and a resistant cystic stage when conditions 45	  
become unfavorable [Lloyd et al., 2001; Coulon et al., 2010]. Acanthamoeba organisms, 46	  
despite being free-life amoebas, can cause a spectrum of human diseases, including 47	  
granulomatous amoebic encephalitis, a rare but fatal infection of the central nervous system 48	  
(CNS), cutaneous lesions,and Acanthamoeba keratitis (AK), a chronic eye infection that 49	  
affects contact lens wearers with an increasing frequency [Marciano-Cabral and Cabral 2003; 50	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Visvesvara et al., 2007]. Despite the social and clinical impact there is no vaccine, and 51	  
current therapy for prevention and treatment of Acanthamoeba infection is limited or 52	  
inadequate. The first-line of treatment of AK is topical therapy with biguanides, such as 53	  
polyhexamethylene biguanide or in combination with diamidines, such as propamidine, 54	  
aminoglycosides or imidazoles [Kumar and Lloyd 2002; Seal 2003]. However, current 55	  
treatment of AK has non-specific effects, can be problematic and relapses are common [Elder 56	  
et al., 1994; Tseng et al., 1998; Lorenzo-Morales et al. 2015]. These challenges make exigent 57	  
the need for identification of new and more effective anti-Acanthamoeba drugs. 58	  
Research and development costs associated with successful market release of anti-59	  
Acanthamoeba therapeutics can be high, driving a continuous demand to develop new 60	  
effective preclinical tools that can identify lead compounds and weed out weak candidates at 61	  
an early stage in the drug discovery program. Any anti-Acanthamoeba drug susceptibility 62	  
testing program aimed at discovering novel compounds requires the availability of reliable 63	  
screening assays. In vitro drug testing platforms are valuable tools for screening of 64	  
chemotherapeutic agents and provide preliminary data for in vivo studies. Trophozoite 65	  
counting methods have been developed, but a major limitation of these assays is the lack of 66	  
sensitivity [Buck and Rosenthal, 1996; Narasimhan and Madhavan, 2002; Ondarza et al., 67	  
2006]. Acanthamoeba-based screening assays are constantly undergoing improvements 68	  
toward higher throughput and reduced reagent consumption. In this regard, drug 69	  
susceptibility testing using colorimetric cell-based assays in microtiter plate format has been 70	  
an essential methodology in drug discovery, allowing many samples to be analyzed rapidly 71	  
and simultaneously using chemicals that stain the cells directly, or that are metabolized into 72	  
colored products [Weyermann et al., 2005]. A few microtiter plate-based methods have been 73	  
developed to screen novel compounds against Acanthamoeba trophozoites [McBride et al., 74	  
2005; Heredero-Bermejo et al., 2015]. However, there is still a need for the development of 75	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more affordable assays with improved readouts in order to enable the testing of a larger 76	  
number of compounds and identification of new drug candidates. 77	  
Sulforhodamine B (SRB) is a bright-pink aminoxanthene dye that binds to basic amino 78	  
acids of cellular proteins under mild acidic conditions, and dissociates under basic conditions 79	  
[Vichai and Kirtikara, 2006]. The binding of SRB is stoichiometric, and the amount of dye 80	  
extracted from stained cells is directly proportional to the total protein mass and therefore 81	  
correlates to cell number [Vichai and Kirtikara, 2006]. A spectrophotometer is used to 82	  
quantify the intensity of the color, producing quantitative data (optical absorbance values) 83	  
that correlates with the number of cells present. The SRB colorimetric assay was originally 84	  
developed for in vitro anticancer-drug screening [Skehan et al., 1990; Shoemaker, 2006; 85	  
Vichai and Kirtikara 2006] and was used for the evaluation of cell proliferation in a 96-well 86	  
plate assay [Lin et al., 1999]. 87	  
In the present study, we investigated whether a quantitative SRB colorimetric assay can 88	  
be developed for testing molecules with anti-Acanthamoeba activity. Here, we describe the 89	  
characteristics of this new SRB assay including defining the optimal culture conditions, 90	  
seeding density and spectral measurement. To assess the sensitivity of the assay we 91	  
determined the IC50 of chlorhexidine, a widely used antimicrobial with a documented anti-92	  
Acanthamoeba activity. Our findings indicate that SRB protein staining is a sensitive in vitro 93	  
high-throughput method that can be used to expedite the discovery of new anti-94	  
Acanthamoeba drug candidates. 95	  
 96	  
2.   Materials and Methods 97	  
 98	  
2.1. Acanthamoeba strains and culture conditions 99	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Two strains of Acanthamoeba castellanii were used as test organisms, a genotype T3 100	  
clinical AK strain was kindly provided by the University Institute of Tropical Diseases and 101	  
Public Health of the Canary Islands, University of La Laguna and Neff strain of genotype T4 102	  
that was originally obtained from American Type Culture Collection (ATCC; 30010). Strains 103	  
belonging to genotypes T3 and T4 share close genetic similarity and have been frequently 104	  
observed in AK infections. Each strain was maintained in axenic peptone-yeast-glucose 105	  
(PYG) growth media containing 0.75% proteose peptone, 0.75% yeast extract and 1.5% 106	  
glucose containing 40µg gentamicin ml−1 (Biochrom AG, Cultek, Granollers, Barcelona, 107	  
Spain). Cultures were fed with fresh medium every week to maintain A. castellanii 108	  
trophozoites in 75-cm2 tissue culture flasks. 109	  
 110	  
2.2.Relationship between optical density and trophozoites’ count 111	  
The choice of wavelength is an important consideration for correlating optical density 112	  
with the number of A. castellanii trophozoites. Hence, we assessed the absorption spectra of 113	  
serial dilutions of A. castellanii trophozoites and examined the relationship between seeding 114	  
density (i.e. number of trophozoites) and absorbance within the wavelength range 450-630 115	  
nm. A. castellanii trophozoites were harvested by keeping culture flasks chilled on ice for 5 116	  
min to detach adherent trophozoites, which were then separated from PYG medium by 117	  
centrifugation at 1000g for 5 min. From a stock solution of 8 × 105 ml−1 A. castellanii 118	  
trophozoites seven serial dilutions (50, 100, 250, 500, 1000, 2500 and 5000 119	  
trophozoites/well) were made and seeded in triplicates in a 96-well microtiter plate in order to 120	  
generate a calibration curve. Control wells were filled with equal volume of culture medium, 121	  
but without trophozoites. Adherence of trophozoites was checked using a Leica DM IL 122	  
inverted microscope (Leica, Wetzlar, Germany). After 30 min trophozoites were fixed and 123	  
stained with sulforhodamine B (SRB) as described below. Measurements were corrected by 124	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blank wells containing PYG medium only. A logarithmic transformation was performed for 125	  
both optical density (OD) values and the numbers of trophozoites to standardize the variance 126	  
and balance the differences between the data points. These transformed data were used to fit a 127	  
linear regression curve. 128	  
 129	  
2.3. Acanthamoeba seeding density optimization 130	  
To determine the optimal density of A. castellanii to be used in the drug susceptibility 131	  
testing, trophozites ranging from 100 to 2000 trophozoites/well were prepared, in triplicates 132	  
to a final volume of 100 µl/well in a 96-well tissue culture plate. After 30 min incubation, the 133	  
trophozoites were fixed and stained with SRB assay using a method modified from that 134	  
described previously [Vichai and Kirttikara, 2006]. Briefly, without removing the culture 135	  
medium, 25 µl cold (4°C) Trichloroacetic acid (50% w/v) (TCA, Merck, Germany) was 136	  
added to each well, already containing 100 µl PYG medium, and the plate was incubated at 137	  
4ºC for 1 hr. The supernatant was then discarded, and the plate was washed gently three times 138	  
with slow-running tap water to remove TCA, culture medium and dead (unattached) 139	  
trophozoites and the plates were left to dry at ambient temperature. About 25 µl of 140	  
sulforhodamine B solution (4 % w/v SRB dissolved in 1% acetic acid in water) (Sigma) was 141	  
added to each well, and the culture was incubated for 15 min. Unbound SRB was removed by 142	  
washing three times with 1% acetic acid. Then, the plates were air-dried completely. Cell 143	  
protein-bound dye was solubilized by adding 150 µl Tris base [tris-(hydroxymethyl)-144	  
aminomethane] solution (10 mM, pH 10.5) to each well, followed by shaking the plate on a 145	  
gyratore shaker for 5-10 min. Optical density (OD) of each well was measured using 146	  
BioTek's PowerWave XS absorbance microplate reader in dual wavelength mode. The color 147	  
absorbance was measured spectrophotometrically at 562 nm as the test wavelength. The 148	  
reference wavelength was 630 nm. OD values were corrected for background OD from blank 149	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wells containing PYG medium only. The OD value of each well was compared to obtain the 150	  
optimal seeding concentration of A. castellanii. 151	  
 152	  
2.4.In vitro susceptibility testing 153	  
The in vitro susceptibly of A. castellanii strains to chlorhexidine (CHX, Sigma) was 154	  
tested based on the SRB method. The optimal seeding density number A. castellanii 155	  
trophozoites, determined to be 500/well, was seeded in triplicates in 100 µl of PYG medium 156	  
in 96-well culture plates. Trophozoites were allowed to adhere to the well surface for 30 min. 157	  
Culture media was then removed and 100 µl of serial dilutions of chlorhexidine (0.15, 0.31, 158	  
0.62, 1.25, 1.5, 3, 6, 12 µM) in PYG medium was added to each well. Chlorhexidine was 159	  
selected because it is commonly used in contact lens cleaning solutions due to its broad-band 160	  
antimicrobial and topical disinfectant activities. After 96 hr of incubation the test plates were 161	  
subjected to the SRB staining in order to assess the inhibitory activity of chlorhexidine. To 162	  
validate the sensitivity of the SRB method a parallel experiment was performed under 163	  
identical conditions to test the efficacy of chlorhexidine against A. castellanii, by direct-164	  
counting of trophozoites using a haemocytometer and an optical microscope at ×40 165	  
magnification. All experiments were performed in triplicates and were repeated 166	  
independently at least three times. 167	  
 168	  
2.5.Statistical analysis 169	  
The half maximal inhibitory concentration (IC50) values were calculated by Probit 170	  
regression. IC50 values, from at least three separate experiments, were compared using 171	  
Student’s t-test. Data are presented as the means ± standard error of the means (SEM). 172	  
Differences were significant when the P value was <0.05. Statistical analyses were performed 173	  
with GraphPad Prism 6.0 (GraphPad Software, San Diego, CA). 174	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 175	  
3.   Results and Discussion 176	  
In this study, we leveraged the simplicity and sensitivity of the sulforhodamine B (SRB) 177	  
staining assay to develop a new method to facilitate high-throughput anti-Acanthamoeba drug 178	  
screening. This method relies on the ability of SRB to bind to protein components of A. 179	  
castellanii trophozoites adherent to culture plates. To adapt the SRB assay to A. castellanii 180	  
the effect of absorbance range and the trophozoite’s seeding density on the performance of 181	  
the assay was investigated. 182	  
We first evaluated the absorption spectra of serial dilutions of Acanthamoeba 183	  
trophozoites and investigated the relationship between the concentration of trophozoites (i.e. 184	  
trophozoite’s seeding density) and absorbance within the wavelength range 450-630 nm. As 185	  
shown in Fig. 1a, the SRB method allows the detection of even small differences in number 186	  
of A. castellanii trophozoites, confirming the sensitivity of the method. At the wavelength of 187	  
maximal absorbance of SRB (562 nm) we were able to detect trophozoite densities at as low 188	  
as 100 trophozoites per well. Regression analysis demonstrated a linear relationship between 189	  
OD readings and the seeding density of A. castellanii trophozoites up to 2000 trophozoites 190	  
per well (Fig. 1b). Next, we determined the optimal number of Acanthamoeba trophozoites 191	  
per well to be used in the SRB assay. At cell seeding density of 500 cells per well, 192	  
trophozoites reached confluence as indicated by the change in the slope of the curve (Fig.1c). 193	  
Hence, 500 cells per well were considered the optimal seeding density for the drug testing 194	  
experiment. This represents an improvement over the standard Alamar Blue assay, which 195	  
requires a 100% reduction of the dye (in control wells), which is achieved with a very high 196	  
density of trophozoites/well. Alamar Blue also requires a certain exposure time, depending on 197	  
the concentration of trophozoites, for the dye to be reduced. In contrast, the SRB method does 198	  
not require time-critical steps and sample preparation can be performed in less than 90 min. 199	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Also, stained plates can be stored at the fixing and staining steps for at least one month for 200	  
later processing. SRB staining is also less sensitive to environmental fluctuation, such as 201	  
variations in pH or depletion of glucose, and is independent of intermediary metabolism - 202	  
factors that may be influenced by the test compounds.  203	  
Acanthamoeba castellanii trophozoites vary in size from 25 to 40 µm [Marciano-Cabral 204	  
and Cabral, 2003]. Therefore, it can be argued that A. castellanii trophozoites can vary in 205	  
volume with growth phases or with different strains and that this subtle variation in the size 206	  
of trophozoites could alter the protein content of trophozoites and thus influences the SRB 207	  
measurements. However, even if Acanthamoeba strain- or subtype-dependent variability in 208	  
the growth of trophozoites exists this was insufficient to affect the measurement of average 209	  
protein concentration of a proliferating population of trophozoites. Also, the SRB assay has 210	  
been developed using clonal strains and identical number of trophozoites in each well.  211	  
We further tested the anti-A. castellanii activity of serial dilutions of chlorhexidine using 212	  
the SRB assay. Fig. 2 shows the dose-response effect of chlorhexidine on the growth of two 213	  
clinical strains of A. castellanii. The IC50 values of chlorhexidine using the SRB assay were 214	  
4.68±0.6 µM and 5.69±0.9 µM for Neff strain and T3 stain, respectively and by using manual 215	  
count was 3.72±0.4 µM for Neff strain. Despite the fact that removal of PYG medium post-216	  
fixation and before the addition of the reagents might have caused loss of some trophozoites 217	  
that are not firmly attached to the culture plate, chlorhexidine IC50 values obtained with SRB 218	  
staining in the present study were found comparable to the IC50 reported using the Alamar 219	  
Blue method [McBride et al., 2005; Martín-Navarro et al, 2008] and the OCR cytotoxicity 220	  
assay [Heredero-Bermejo et al., 2015], further supporting the reliability of the SRB method. 221	  
Apparent differences in the intensity of the colour between wells seeded by two A. castellanii 222	  
strains are observed. Wells exposed to lower chlorhexidine concentrations developed more 223	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intense colour and correlated with high OD readings, reflecting large number of trophozoites 224	  
(Fig. 3). 225	  
A few methods have been developed to screen compounds against A. castellanii 226	  
trophozoites. The traditional cell counting methods using haemocytometer and staining, such 227	  
as trypan blue are simple and inexpensive but very time-consuming, labor intensive and 228	  
sometimes inaccurate [Buck and Rosenthal, 1996; Narasimhan and Madhavan, 2002; 229	  
Ondarza et al., 2006]. Measurement of mitochondrial metabolic rate using MTT (3-(4,5-230	  
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay or MTS assay to indirectly 231	  
reflect viable cell numbers has been applied [O'Toole et al., 2003]. MTT is a tetrazolium salt 232	  
that is reduced to purple formazan crystals mainly by mitochondrial succinate dehydrogenase 233	  
[Wang et al., 1996]. MTS assay utilizes a tetrazolium salt [3-(4,5-dimethylthiazol-2-yl)-5-(3-234	  
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] that is an alternative to MTT. 235	  
The formazan formed from MTS is water-soluble and less toxic in contrast to the insoluble 236	  
formazan product formed by MTT. In both assays, the colour intensity of the formazan dye 237	  
correlates to the number of viable cells. 238	  
Although useful, viability assays can be prone to a number of factors that can adversely 239	  
affect the results. For example, some chemicals or phytochemicals may interact with MTT 240	  
directly even in the absence of cells [Lim et al., 2015]. Also, cell metabolic activity may be 241	  
influenced by different culture conditions or chemical treatments, which can cause 242	  
considerable variations in the results reported from these assays [Plumb et al., 1989]. The 243	  
comparative efficacy of using PrestoBlue®, MTT and CellTiter96® in assessing the effect of 244	  
chlorhexidine digluconate on A. castellanii and A. polyphaga indicated that results can be 245	  
influenced by the strain used, the viability of trophozoites and the interference of the culture 246	  
medium [Heredero-Bermejo et al., 2013]. However, these factors could also influence any 247	  
test, not only PrestoBlue®, MTT or CellTiter96® assays. The colorimetric assay based on the 248	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mitochondrial reduction of Alamar Blue® [McBride et al., 2005] requires expensive reagents 249	  
and high trophozoite seeding density, limiting their ability to be used in high throughput 250	  
screening of large library of chemicals. A newly developed microplate method based on the 251	  
real-time measurement of oxygen concentration rate (OCR) of cultured trophozoites has 252	  
proved to be sensitive and reliable for testing compounds with anti-Acanthamoeba activity 253	  
[Heredero-Bermejo et al., 2015]. This OCR-based method enables real-time assessment of 254	  
cytotoxicity while maintaining the high-throughput drug screening capability. Even though 255	  
this method requires the addition of mineral oil to wells no addition of substrate is need, an 256	  
improvement over other methods including the SRB assay.   257	  
In conclusion, our work represents the first application of the SRB staining method in 258	  
anti-Acanthamoeba drug screening research. This high-throughput, colorimetric method can 259	  
enable the screening of large libraries of chemical molecules against Acanthamoeba 260	  
trophozoites in a microtiter plate format. The method promises an effective and inexpensive 261	  
preclinical tool that can accelerate the screening of prospective therapeutics, while increasing 262	  
the translational predictive value of in vitro drug testing studies and reducing the need for in 263	  
vivo animal-based experiments. This SRB method also has potential to be used in the future 264	  
for the rapid drug susceptibility testing of clinical A. castellanii isolates from infected 265	  
patients. Since our interests lie in developing this new SRB assay we have only tested one 266	  
drug in this study. A useful future direction would be to explore a library of compounds with 267	  
different mechanism of actions in parallel with another established assay in order to test the 268	  
utility of the SRB assay. Finally, because protein content, metabolism and OCR can all be 269	  
influenced by cytotoxic drugs in different manners, multiplexing assays measuring these 270	  
parameters simultaneously is the best way to get the true picture of response of A. castellanii 271	  
trophozoites to toxic agents. 272	  
 273	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 370	  
Fig. 1. Calibration curve of SRB assay on Acanthamoeba castellanii trophozoites was 371	  
constructed of optical density (OD) values against the numbers of trophozoites for the 372	  
validation of linearity. A. castellanii trophozoites were seeded at the indicated cell densities 373	  
per well. The SRB method was performed 30 min after seeding as described in the materials 374	  
and methods. (a) Profiles of the spectra of normalized OD between 450 and 630nm versus 375	  
SRB-stained trophozoites in a series of seeding densities. (b) Calibration curve of trophozoite 376	  
numbers against OD at 562 nm (OD562), showing a linear relationship between trophozoite 377	  
density and absorbance produced by the stained trophozoites with a R2 correlation coefficient 378	  
of 0.9988. (C) Relationship between trophozoite’s seeding density and absorbance. All 379	  
results represent the mean of three independent experiments. 380	  
 381	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Fig. 2. Effect of chlorhexidine exposure on the growth rate of two clinical strains of 390	  
Acanthamoeba castellanii. Dose-response curve of cultures of A. castellanii after 96 hr 391	  
exposure to chlorhexidine at serial dilutions (0.15, 0.31, 0.62, 1.25, 1.5, 3, 6, 12 µM). The 392	  
number of A. castellanii trophozoites was determined by the SRB staining method. 393	  
Progressive inhibition of trophozoites’ growth was detected in Neff strain (triangles) and T3 394	  
strain (squares) with exposure to increasing concentrations of chlorhexidine. Each data point 395	  
represents the mean ± SEM for nine samples (triplicate samples in three independent 396	  
experiments). 397	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 400	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Fig. 3. Representative micrographs of microtitre plates stained with SRB showing the 406	  
inhibitory effect of chlorhexidine on trophozoites of two Acanthamoeba castellanii strains 407	  
(Neff and T3) at 72 hrs after exposure to chlorhexidine. The plate was designed as follows: 408	  
(C) control untreated wells, (B) blank wells and the test wells showing serial dilutions (100 to 409	  
0.78 µM) of the tested chlorhexidine. Note the change in the color intensity (OD) of the 410	  
wells, which increases with increasing the number of trophozoites per well. 411	  
 412	  
